> top > docs > PMC:7294857 > spans > 645-2163 > annotations

PMC:7294857 / 645-2163 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T8 67-75 SP_7 denotes COVID-19
T9 77-88 NCBITaxon:11118 denotes coronavirus
T10 396-404 SP_7 denotes COVID-19
T11 433-442 UBERON:0002048 denotes pneumonia
T12 517-525 SP_7 denotes COVID-19
T13 598-605 UBERON:0000175 denotes pleural
T14 637-649 UBERON:0005169 denotes interstitial
T15 666-684 CL:0009002 denotes inflammatory cells
T16 712-716 UBERON:0002048 denotes lung
T17 814-832 CL:0009002 denotes inflammatory cells
T18 923-935 SP_10 denotes severe acute
T19 936-947 SP_10;UBERON:0001004 denotes respiratory
T20 948-965 SP_10 denotes distress syndrome
T21 1046-1060 CHEBI:35718;CHEBI:35718 denotes antibacterials
T22 1062-1075 CHEBI:35718;CHEBI:35718 denotes antimalarials
T23 1172-1183 GO:0015671 denotes oxygenation
T24 1350-1368 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T25 1373-1385 CHEBI:2955;DG_6;CHEBI:2955 denotes azithromycin
T56553 67-75 SP_7 denotes COVID-19
T45867 77-88 NCBITaxon:11118 denotes coronavirus
T27920 396-404 SP_7 denotes COVID-19
T71476 433-442 UBERON:0002048 denotes pneumonia
T7264 517-525 SP_7 denotes COVID-19
T71734 598-605 UBERON:0000175 denotes pleural
T8197 637-649 UBERON:0005169 denotes interstitial
T7587 666-684 CL:0009002 denotes inflammatory cells
T70759 712-716 UBERON:0002048 denotes lung
T14767 814-832 CL:0009002 denotes inflammatory cells
T43152 923-935 SP_10 denotes severe acute
T87220 936-947 SP_10;UBERON:0001004 denotes respiratory
T32681 948-965 SP_10 denotes distress syndrome
T41512 1046-1060 CHEBI:35718;CHEBI:35718 denotes antibacterials
T7518 1062-1075 CHEBI:35718;CHEBI:35718 denotes antimalarials
T45912 1172-1183 GO:0015671 denotes oxygenation
T91011 1350-1368 CHEBI:5801;DG_20;CHEBI:5801 denotes hydroxychloroquine
T30341 1373-1385 CHEBI:2955;DG_6;CHEBI:2955 denotes azithromycin

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T3 679-684 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T4 712-716 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T5 827-832 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T2 598-614 Body_part denotes pleural effusion http://purl.obolibrary.org/obo/UBERON_0000175
T3 712-716 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 67-75 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 396-404 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 433-442 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T6 517-525 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 616-631 Disease denotes lymphadenopathy http://purl.obolibrary.org/obo/MONDO_0005833
T8 930-965 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T9 936-965 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T10 967-971 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T8 352-353 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 598-614 http://purl.obolibrary.org/obo/UBERON_0000175 denotes pleural effusion
T10 679-684 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T11 712-716 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T12 712-716 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T13 827-832 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T14 1163-1171 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T15 1333-1334 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T5 1034-1044 Chemical denotes antivirals http://purl.obolibrary.org/obo/CHEBI_22587
T6 1046-1060 Chemical denotes antibacterials http://purl.obolibrary.org/obo/CHEBI_33282
T7 1062-1075 Chemical denotes antimalarials http://purl.obolibrary.org/obo/CHEBI_38068
T8 1132-1138 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T9 1350-1368 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T10 1373-1385 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 433-442 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T2 598-614 Phenotype denotes pleural effusion http://purl.obolibrary.org/obo/HP_0002202
T3 616-631 Phenotype denotes lymphadenopathy http://purl.obolibrary.org/obo/HP_0002716
T4 936-956 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T9 0-229 Sentence denotes We searched using PubMed and Google Scholar using keywords such as COVID-19, coronavirus, and their combination with pathological findings, clinical features, management, and treatment to search for relevant published literature.
T10 230-383 Sentence denotes After the removal of duplications and the selection of only published English literature from the past five years, we had a total of 31 papers to review.
T11 384-502 Sentence denotes Most of the COVID-19 affected patients have mild pneumonia symptoms, and those with severe disease have comorbidities.
T12 503-685 Sentence denotes Patients with COVID-19 had pathological findings, like ground-glass opacities, consolidations, pleural effusion, lymphadenopathy, and interstitial infiltration of inflammatory cells.
T13 686-851 Sentence denotes Radiological changes show lung changes such as consolidations and opacities, and the pathological findings were infiltration of inflammatory cells and hyalinization.
T14 852-1001 Sentence denotes Patients with mild symptoms should self-quarantine, whereas those with severe acute respiratory distress syndrome (ARDS) are treated in the hospital.
T15 1002-1102 Sentence denotes Medications under trial include antivirals, antibacterials, antimalarials, and passive immunization.
T16 1103-1225 Sentence denotes Supportive treatment such as oxygen therapy, extracorporeal membrane oxygenation, and ventilator support can also be used.
T17 1226-1289 Sentence denotes The symptoms shown by patients are very mild and self-limiting.
T18 1290-1518 Sentence denotes There is no definitive treatment, although a combination of hydroxychloroquine and azithromycin have shown good results, and passive immunization also shows promising results, their safety profile is yet to be studied in detail.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
35 517-525 Disease denotes COVID-19 MESH:C000657245
36 598-614 Disease denotes pleural effusion MESH:D010996
37 616-631 Disease denotes lymphadenopathy MESH:D008206
38 930-965 Disease denotes acute respiratory distress syndrome MESH:D012128
39 967-971 Disease denotes ARDS MESH:D012128
25 67-88 Species denotes COVID-19, coronavirus Tax:2697049
26 414-422 Species denotes patients Tax:9606
27 503-511 Species denotes Patients Tax:9606
28 852-860 Species denotes Patients Tax:9606
29 1248-1256 Species denotes patients Tax:9606
30 1132-1138 Chemical denotes oxygen MESH:D010100
31 1350-1368 Chemical denotes hydroxychloroquine MESH:D006886
32 1373-1385 Chemical denotes azithromycin MESH:D017963
33 396-404 Disease denotes COVID-19 MESH:C000657245
34 433-442 Disease denotes pneumonia MESH:D011014